Epivir
NDC Package 53808-0893-1
Package Information
Epivir is hBV is indicated for the treatment of chronic hepatitis B virus (HBV) infection associated with evidence of hepatitis B viral replication and active liver inflammation [see Clinical Studies (14.1, 14.2)].The following points should be considered when initiating therapy with EPIVIR-HBV:•Due to high rates of resistance development in treated patients, initiation of treatment with EPIVIR-HBV should only be considered when the use of an alternative antiviral agent with a higher genetic barrier to resistance is not available or appropriate.•EPIVIR-HBV has not been evaluated in patients co-infected with HIV, hepatitis C virus (HCV), or hepatitis delta virus.•EPIVIR-HBV has not been evaluated in liver transplant recipients or in patients with chronic hepatitis B virus infection with decompensated liver disease.•EPIVIR-HBV has not been evaluated in pediatric patients younger than 2 years of age with chronic HBV infection. Marketed by State Of Florida Doh Central Pharmacy, this product is identified by NDC 53808-0893 and is authorized under FDA application NDA021003.
Identification & Billing
- RxCUI: 205328 - lamiVUDine 100 MG Oral Tablet
- RxCUI: 205328 - lamivudine 100 MG Oral Tablet
- RxCUI: 205328 - 3TC 100 MG Oral Tablet
- RxCUI: 213483 - Epivir-HBV 100 MG Oral Tablet
- RxCUI: 213483 - lamivudine 100 MG Oral Tablet [Epivir HBV]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 53808 - State Of Florida Doh Central Pharmacy
- 53808-0893 - Epivir
- 53808-0893-1 - 30 TABLET, FILM COATED in 1 BLISTER PACK
- 53808-0893 - Epivir
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53808-0893-1 identifies a specific commercial package of 30 tablet, film coated in 1 blister pack of Epivir Hbv, labeled by State Of Florida Doh Central Pharmacy. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by State Of Florida Doh Central Pharmacy on January 01, 2014. The current certification is valid through December 31, 2017.
How is this State Of Florida Doh Central Pharmacy product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53808089301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.